|
T&L is a South Korean specialty materials company that develops and manufactures high-functionality polymer-based products for medical and industrial applications. The company's core business involves the production of advanced wound dressings, including hydrocolloid, polyurethane foam, hydrogel, alginate, and silicone types, which are used to protect wounds, absorb exudate, and promote healing. T&L also manufactures orthopedic fixation devices such as casts and splints for fracture treatment and support. Leveraging its polymer technology, the company produces micro-needles for transdermal drug delivery and cosmetic applications, as well as semi-finished materials supplied to medical device and cosmetic manufacturers. Additionally, T&L develops chemical products such as water-based resins, curing agents, functional additives, and polyurethane foams for use in coatings, textiles, and synthetic leather. The company serves domestic hospitals, clinics, and pharmacies through a network of distributors and ODM partnerships with major pharmaceutical companies, while expanding its international presence through overseas agents and participation in global medical trade shows in the United States, Germany, China, and the Middle East. Founded in 1998, T&L operates an in-house research center focused on polymer engineering, biotechnology, and chemical engineering to drive product innovation. Summarised from the company's own disclosures, fiscal year ended Mar 2026 |
Industry Medical Devices | Homepage tnl.co.kr |
| Sector Healthcare | IR page — | |
|
Tags
wound dressings, hydrocolloid, polyurethane foam, micro-needles, orthopedic fixation, transdermal drug delivery, polymer materials, medical devices, odm manufacturing, cosmetic ingredients, Illumiel, T&L Healthcare
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | — |
| Market cap (USD) | — |
| P/E | — |
| PEG | — |
| P/BV | — |
| P/S | — |
| P/OCF | — |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 20.4% |
| ROI | 18.9% |
| ROIC | 18.3% |
| Profit margin | 23.2% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | 21.7% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | — |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | — |
| Quality score | 0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||
| Trade receivables (KRW) | 4.57B | 5.96B | 7.08B | 8.12B | 13.3B | 9.88B | 16.3B | 16.7B |
| ↳ YoY growth | +30.4% | +18.8% | +14.6% | +63.4% | -25.6% | +64.8% | +2.7% | |
| ↳ 5y CAGR | +16.7% | +22.2% | +18.7% | |||||
| Other receivables (KRW) | — | — | — | — | — | — | — | 18.1B |
| Borrowings, current (KRW) | 995M | 632M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Lease liabilities (KRW) | 33.6M | 19.8M | 87.4M | 249M | 120M | 112M | 452M | 318M |
| Cash and deposits (KRW) | 2.77B | 4.9B | 14.6B | 16.6B | 20.6B | 19.3B | 60.7B | 73.7B |
| Intangible assets (KRW) | 1.24B | 995M | 1.37B | 1.74B | 1.71B | 3.11B | 3.64B | 3.74B |
| Net debt (borrowings + leases - cash) (KRW) | -1.74B | -4.24B | -14.5B | -16.4B | -20.5B | -19.2B | -60.3B | -73.4B |
| Cash flow detail | ||||||||
| Operating cash flow (KRW) | 6.39B | 7.83B | 9.34B | 19B | 15.4B | 32.6B | 46.6B | 37.7B |
| Purchases of property, plant and equipment (KRW) | -2.65B | -3.86B | -2.98B | -15.6B | -16B | -13.5B | -15.8B | -17.6B |
| Purchases of intangible assets (KRW) | -163M | -418M | -461M | -382M | -10.4M | -1.45B | -581M | -500M |
| Dividends paid (cash effect) (KRW) | -960M | -960M | -1.28B | -1.63B | -3.25B | -3.63B | -4.44B | -6.05B |
| Share buybacks (cash effect) (KRW) | — | — | — | 0.00 | -1.88B | -35,700 | 0.00 | -3.27B |
| Interest paid (cash effect) (KRW) | -134M | -99.7M | -30.1M | -3.9M | -33.5M | -8.74M | -19.6M | -13.4M |
| Income taxes paid (cash effect) (KRW) | -406M | -623M | -1.48B | -1.39B | -5.24B | -4.59B | -9.82B | -15.1B |
| Free cash flow (OCF - PPE - intangibles) (KRW) | 3.58B | 3.55B | 5.9B | 2.99B | -598M | 17.7B | 30.2B | 19.6B |
| Income detail | ||||||||
| Total comprehensive income (KRW) | 4.44B | 6.95B | 10.1B | 19.8B | 21.1B | 27.1B | 46.3B | 38.4B |
| Comprehensive income to owners (KRW) | 4.44B | 6.95B | 10.1B | 19.8B | 21.1B | 27.1B | 46.3B | 38.4B |
| Reported | Mar 17, 2021 | Mar 17, 2021 | Mar 17, 2021 | Mar 18, 2024 | Mar 18, 2024 | Mar 18, 2024 | Mar 17, 2025 | May 15, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpNews
Disclosures filed with DART (material events and exchange disclosures), newest first, headlines as filed in Korean. The link opens the filing on DART. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding T&L
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
